Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Patents

Prostat Adenokarsinomu Tedavisi İçin Kullanima Uygun Yeni Etken Bileşikler

PatentProstate Cancer

21.10.2024

Prostat Adenokarsinomu Tedavisi İçin Kullanima Uygun Yeni Etken Bileşikler from TRUSTLIFE

ÖZET

Buluş, prostat adenokarsinom hastalığının tedavisinde etkinlik gösterdiği kanıtlananyeni bileşikler ile ilgilidir.

You may also be interested in

  • Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife
    Visits

    Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife

  • Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH
    Scientific Documents

    Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH

  • Novel pyrimidine derivatives as potent BUB1B inhibitors for clear cell renal cell carcinoma: From synthesis and characterization to docking insights and therapeutic validation
    Scientific Documents

    Novel pyrimidine derivatives as potent BUB1B inhibitors for clear cell renal cell carcinoma: From synthesis and characterization to docking insights and therapeutic validation

Trustlife
About Trustlife Labs Drug R&D Center Contact